Publication
Large increase in bloodstream infections with carbapenem-resistant Acinetobacter species during the first 2 years of the COVID-19 pandemic, EU/EEA, 2020 and 2021
| dc.contributor.author | Kinross, Pete | |
| dc.contributor.author | Gagliotti, Carlo | |
| dc.contributor.author | Merk, Hanna | |
| dc.contributor.author | Plachouras, Diamantis | |
| dc.contributor.author | Monnet, Dominique L | |
| dc.contributor.author | Högberg, Liselotte Diaz | |
| dc.contributor.author | EARS-Net Study Group | |
| dc.contributor.author | EARS-Net Study Group participants | |
| dc.date.accessioned | 2023-03-20T15:57:48Z | |
| dc.date.available | 2023-03-20T15:57:48Z | |
| dc.date.issued | 2022-11-17 | |
| dc.description | EARS-Net Study Group (Portugal: Manuela Caniça). | pt_PT |
| dc.description | EARS-Net Study Group participants: Reinhild Strauss, Karl Mertens, Stefana Sabtcheva, Arjana Tambic Andrasevic, Panagiota Maikanti, Helena Žemličková, Henrik Hasman, Marina Ivanova, Kati Räisänen, Sylvie Maugat, Ines Noll, Kassiani Mellou, Ákos Tóth, Kristján Orri Helgason, Stephen Murchan, Giulia Errico, Ieva Voita, Esther Walser-Domjan, Jolanta Miciulevičienė, Monique Perrin, Elizabeth Anne Scicluna, Sjoukje Hs Woudt, Ørjan Samuelsen, Dorota Żabicka, Manuela Caniça, Gabriel Adrian Popescu, Eva Schréterová, Helena Ribič, Maria Belén Aracil García, Hanna Billström. | |
| dc.description.abstract | Bloodstream infections (BSIs) with Acinetobacter species commonly have poor outcomes, especially in intensive care unit (ICU) patients [1]. Acinetobacter spp. is intrinsically resistant to many antimicrobials, and additional acquired resistance further complicates the treatment of serious infections in already vulnerable patient groups. Recent data from the European Antimicrobial Resistance Surveillance Network (EARS-Net) show a large and statistically significant increase in reports of Acinetobacter spp. BSIs in the European Union (EU) and European Economic Area (EEA) during the period from 2017 to 2021 [2]. Most of this increase occurred in 2020 and 2021, the first years of the coronavirus disease (COVID-19) pandemic. Here we further explore this trend in a subset of data from laboratories that continuously reported data during that period. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Euro Surveill. 2022 Nov;27(46):2200845. doi: 10.2807/1560-7917.ES.2022.27.46.2200845 | pt_PT |
| dc.identifier.doi | 10.2807/1560-7917.ES.2022.27.46.2200845 | pt_PT |
| dc.identifier.issn | 1560-7917 | |
| dc.identifier.uri | http://hdl.handle.net/10400.18/8581 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | European Centre for Disease Prevention and Control | pt_PT |
| dc.relation.publisherversion | https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.46.2200845 | pt_PT |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
| dc.subject | Acinetobacter species | pt_PT |
| dc.subject | AMR | pt_PT |
| dc.subject | COVID-19 | pt_PT |
| dc.subject | Bloodstream infections | pt_PT |
| dc.subject | Resistência aos Antimicrobianos | pt_PT |
| dc.title | Large increase in bloodstream infections with carbapenem-resistant Acinetobacter species during the first 2 years of the COVID-19 pandemic, EU/EEA, 2020 and 2021 | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.issue | 46 | pt_PT |
| oaire.citation.startPage | 2200845 | pt_PT |
| oaire.citation.title | Eurosurveillance | pt_PT |
| oaire.citation.volume | 27 | pt_PT |
| rcaap.embargofct | Acesso de acordo com política editorial da revista. | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |